SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-039495
Filing Date
2023-06-23
Accepted
2023-06-23 17:54:07
Documents
1
Period of Report
2023-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3382
  Complete submission text file 0001209191-23-039495.txt   4871
Mailing Address C/O FIVE PRIME THERAPEUTICS, INC. 2 CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address
Sarena Francis Willard (Reporting) CIK: 0001423786 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39488 | Film No.: 231038953

Mailing Address 900 INDUSTRIAL ROAD, SUITE C SAN CARLOS CA 94070
Business Address 900 INDUSTRIAL ROAD, SUITE C SAN CARLOS CA 94070 650.931.6236
Apexigen, Inc. (Issuer) CIK: 0001814140 (see all company filings)

IRS No.: 851260244 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations